Analyst Price Target is GBX 55
▲ +23.10% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for THG in the last 3 months. The average price target is GBX 55, with a high forecast of GBX 55 and a low forecast of GBX 55. The average price target represents a 23.10% upside from the last price of GBX 44.68.
Current Consensus is
Moderate Buy
The current consensus among 2 polled investment analysts is to moderate buy stock in THG. This rating has held steady since October 2025, when it changed from a Hold consensus rating.
THG (www.thg.com) is a global innovator revolutionising how brands connect to a worldwide consumer base. We are transforming how consumer brands go to market in the digital age.
We have built a portfolio of leading digital beauty, health, wellness, and sports nutrition brands that are capitalising on the global growth opportunities, supported by the accelerating consumer shift to the e-commerce channel.
THG is home to three key divisions: Beauty, Nutrition, and Ingenuity. All brands, whether in-house or third parties are powered by our complete commerce division Ingenuity, which is a flexible and scalable offering formed of a combination of complex e-commerce technologies, physical assets, infrastructure, and brand building capabilities.
THG Beauty is home to leading online pure-play retailers for prestige beauty products and brings together global online multi-brand retail subscription boxes, owned prestige brands along with production and innovation. It operates leading pure-plays sites such as Lookfantastic, Cult Beauty and Dermstore, offering more than 1,300 premium brands across the skincare, haircare, cosmetics and fragrance categories.
THG Nutrition is a group of digital-first nutrition and wellbeing brands, including the world’s largest online sports nutrition brand, Myprotein, and it’s family of brands. The division is driven by a vertically integrated business model and supported by global THG-owned production facilities. The division manufactures and develops over 80% of its nutrition products by revenue in-house through a network of global facilities across the UK, USA and Europe.
Read More